Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-25 @ 9:48 PM
Study NCT ID:
NCT04907851
Status:
COMPLETED
Last Update Posted:
2025-03-17
First Post:
2021-05-25
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)
Sponsor:
Redx Pharma Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-10
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-05-25
First Submit QC Date:
None
Study First Post Date:
2021-06-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-11-07
Results First Submit QC Date:
None
Results First Post Date:
2025-03-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-25
Last Update Post Date:
2025-03-17
Last Update Post Date Type:
ACTUAL